Skip to main content

Circulating thrombotic and haemostatic components in patients with coronary artery disease

Indian Journal of Clinical Biochemistry volume 25, pages 20–28 (2010)Cite this article

Abstract

The study aimed to analyze the circulating levels of thrombotic and haemostatic components; tissue factor, tissue factor pathway inhibitor, tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with acute myocardial infarction at presentation (Group 1, n=49), unstable angina and Non-ST elevated MI after treatment (Group 2, n=22), stable angina (Group 3, n=18) and healthy individuals (Group 4, n=31). Significant finding was increase in tissue factor not only in Group 1 (2.0 fold, P=0.001), Group 2 (2.2 fold, P=0.015) but also in Group 3 (1.8 fold, P=0.018) as compared to controls. In Group 1 Plasminogen activator inhibitor-1 increased significantly (35.8%, P=0.02). Tissue factor pathway inhibitor and tissue plasminogen activator demonstrated increase in Group 1 of age<40 years while insignificant changes in elder patients. Increased thrombotic and decreased fibrinolytic conditions in acute myocardial infarction patients were observed. Increase TF in stable angina demonstrates procoagulant status in these patients as well.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Fuster V, Lewis A. The Conner Memorial Lecture. Mechanisms leading to acute myocardial infarction. Insights from studies of vascular biology. Circulation 1994; 90: 2126–2146.

    CAS  PubMed  Google Scholar 

  2. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, et al. Characterization of the relative thrombogenity of atherosclerotic plaque components: Implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562–1569.

    CAS  PubMed  Google Scholar 

  3. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis. Definition of a thrombotic shear rate threshold. J Am Coll Cardiol 1994; 24: 1091–1097.

    CAS  PubMed  Google Scholar 

  4. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134: 253–259.

    Article  CAS  PubMed  Google Scholar 

  5. Kamikura Y, Wada H, Yamada A, Shimura M, Hivoyama K, Shiku H, et al. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Am J Hematol 1997; 55: 183–187.

    Article  CAS  PubMed  Google Scholar 

  6. Nishiyama K, Ogawa H, Yasue H, Soejima H, Misumi K, Takazoe K et al. Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes. Jpn Circ J 1998; 62: 710–712.

    Article  CAS  PubMed  Google Scholar 

  7. Maly M, Vojacek J, Hrabos V, Kvasnicka J, Salaj P, Durdil V. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome. Physiol Res 2003; 52: 719–728.

    CAS  PubMed  Google Scholar 

  8. Morange PE, Blankenberg S, Alessi MC, Bickel C, Rupprecht HJ, Schnabel S, et al. Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary arterty disease: The AtheroGene Study. J Thromb Hemost 2007; 5: 475–482.

    Article  CAS  Google Scholar 

  9. Xiong SL, Wang Q, Zheng L, Li JL, Wen ZB, He SL. Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1821–1823.

    CAS  PubMed  Google Scholar 

  10. Chen HZ, Jia HY, Song HY, Wang JY. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients. Chin Med J (Engl) 1990; 103: 541–545.

    CAS  Google Scholar 

  11. Sakamoto T, Yasue H, Ogawa H Misumi L, Masuda T. Association of potency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Am J Cardiol 1992; 70: 271–276.

    Article  CAS  PubMed  Google Scholar 

  12. Conri C, Seigneur M, Constans J, Mercier P, Baste JC, Dufourcq P, et al. Evidence of elevated soluble plasma thrombomodulin in atherosclerosis. J Mal Vasc 1993; 18: 112–118.

    CAS  PubMed  Google Scholar 

  13. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Wienehall L, Huhtasaari F, et al. High PAI-1 and tPA levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241–2247.

    CAS  PubMed  Google Scholar 

  14. Mannucci PM, Bernardinelli L, Foco L, Galli M, Ribichini F, Tubaro M, et al. Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women. J Thromb Hemost 2005; 3: 280–286.

    Article  CAS  Google Scholar 

  15. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK. Prospective study of fibrinolytic factors and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001; 21: 611–617.

    CAS  PubMed  Google Scholar 

  16. Ganti Ak, Potti A, Yegnanarayan R. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 levels in acute myocardial infarction. Pathophysiol Haemost Thromb 2002; 32: 80–84.

    Article  CAS  PubMed  Google Scholar 

  17. Mackman N, Morrissey JH, Fowler B, Edgington TS. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochem 1989; 28: 1755–1762.

    Article  CAS  Google Scholar 

  18. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989; 86: 2839–2843.

    Article  CAS  PubMed  Google Scholar 

  19. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841–843.

    CAS  PubMed  Google Scholar 

  20. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon TJ, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311–2315.

    Article  CAS  PubMed  Google Scholar 

  21. Llorente-Cortes V, Otero-Vinas M, Camino-Lopez S, Llampayas O, Badimon L. Aggregated low-density lipoprotein uptake induces membrane tissue factor procoagulant activity and microparticle release in human vascular smooth muscle cells. Circulation 2004; 110: 452–459.

    Article  CAS  PubMed  Google Scholar 

  22. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res 2000; 87: 126–132.

    CAS  PubMed  Google Scholar 

  23. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458–462.

    Article  CAS  PubMed  Google Scholar 

  24. Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 1233–1239.

    Article  CAS  PubMed  Google Scholar 

  25. Lindhal AK. Tissue factor pathway inhibitor: From unknown coagulation inhibitor to major anti thrombogenic principle. Cardiovascular Res 1997; 33: 286–291.

    Article  Google Scholar 

  26. Sandset PM. Tissue factor pathway inhibitor—an update (TFPI). Haemostasis 1996; 26(Suppl 4): 154–165.

    CAS  PubMed  Google Scholar 

  27. Caplice NM, Mueske CS, Kleppe LS, Simari RD. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity. Circulation 1998; 98: 1051–1057.

    CAS  PubMed  Google Scholar 

  28. Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol 1999; 188: 180–188.

    Article  CAS  PubMed  Google Scholar 

  29. Crawley J, Lupu F, Westmuckett AD, Severs NJ, Kakkar VV, Lupu C. Expression, localization and activity of TFPI in normal and atherosclerotic human vessels. Arterioscler Thromb Vasc Biol 2000; 20: 1362–1373.

    CAS  PubMed  Google Scholar 

  30. Guha M, O’Connel MA, Pawlinski R, Hollis A, McGovern P, Yan SF, et al. Lipopolysaccharide activation of the MEK-ERK 1/2 pathway in human monocytic cells mediates tissue expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001; 98: 1429–1439.

    Article  CAS  PubMed  Google Scholar 

  31. Ott I, Andrassy M, Zieglgansberger D, Geith S, Schomig A, Neumann FJ. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001; 97: 3721–3726.

    Article  CAS  PubMed  Google Scholar 

  32. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 2002; 22(4): 539–548.

    Article  CAS  PubMed  Google Scholar 

  33. Mousa SA. Inhibitory effect of C-reactive protein on the release of tissue factor pathway inhibitor from human endothelial cells: reversal by low molecular weight heparin. Int Angiol 2006: 10–13.

  34. Saito Y, Wada H, Yamamuro M, Inoue A, Shimura M, Hiyoyama K, et al. Changes in plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease. Am J Hematol 1999; 61: 238–242.

    Article  CAS  PubMed  Google Scholar 

  35. Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998; 79:495–499.

    CAS  PubMed  Google Scholar 

  36. Al-Nozha MM, Abdel-Gader AG, Arafah MR, Al-Maatouq MA, Al-Shahid MS, Al-Harthi SS, et al. Tissue factor pathway inhibitor, natural coagulation inhibitors and hemostatic activation markers in patients with acute coronary syndromes. Saudi Med J 2005; 26: 937–942.

    PubMed  Google Scholar 

  37. Novo G, Caplice N, Tantillo R, Bonura F, Simari R, Novo S. TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications. Int Angiol 2005; 24; 366–371.

    CAS  PubMed  Google Scholar 

  38. Wang HB, Kang WQ, Song DL, Wang X, Ren GR, Teng JL, et al. Relationship between tissue type plasminogen activator and coronary vulnerable plaque in patients with acute coronary syndrome: virtual histological study. Chin Med J (Engl) 2008; 121: 540–543.

    CAS  Google Scholar 

  39. Hoffmeister HM, Jur M, Ruf-Lehmann M, Helber U, Heller W, Seipel L. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction. J Am Coll Cardiol 1998; 31: 547–551.

    Article  CAS  PubMed  Google Scholar 

  40. Yan J, Huang Z, Liu R, Li L, Han C, Yang J. A study on the reserve capacity of endothelial tissue plasminogen activator in patients with acute coronary syndrome. Zhonghua Nei Ke Za Zhi 1999; 38: 817–820.

    CAS  PubMed  Google Scholar 

  41. Hoffmeister HM, Heller W, Seipel L. Blood coagulation and fibrinolysis in arteriosclerosis Z Kardiol 1999; 88: 315–323.

    Article  CAS  PubMed  Google Scholar 

  42. Shindo J, Ishibashi T, Kijima M, Nakazato K, Nagata K, Yokoyama K, et al. Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes. Coron Artery Dis 2001; 12: 573–579.

    Article  CAS  PubMed  Google Scholar 

  43. Chen F, Eriksson P, Hansson GK, Herzfeld I, Klein M, Hansson LO, et al. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 2005; 15: 57–65.

    CAS  PubMed  Google Scholar 

  44. Thogersen AM, Jansson JH, Boman K, Nilsson TK, Wienehall L, Huhtasaari F, et al. High PAI-1 and tPA levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241–2247.

    CAS  PubMed  Google Scholar 

  45. Hamstein A Wiman B, de Faire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–1563.

    Article  Google Scholar 

  46. Chen Y, Wang J, Yao Y, Yuan W, Kong M, Lin Y, et al. CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-kappaB and ERK 1/2 MAPK pathway. FEBS Lett 2009; 583: 2811–2818.

    Article  CAS  PubMed  Google Scholar 

  47. Wu J, Stevenson MJ, Brown JM, Grunz EA, Strawn TL, Fay WP. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler Thromb Vasc Biol 2008: 698–704.

  48. Cirillo P, Golino P, Calabro P, Cali G, Ragni M, De Rosa S, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005; 68: 47–55.

    Article  CAS  PubMed  Google Scholar 

  49. Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005: 2216–2221.

Download references

Author information

Affiliations

  1. H. N. Medical Research Society, Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    Kavita K. Shalia, R. A. Mokal, S. M. Mithbawkar, K. V. Kudalkar, A. Abraham & P. K. Thakur

  2. Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004, India

    V. K. Shah, M. R. Mashru, S. L. Soneji & J. B. Vasvani

  3. Rajawadi Municipal Hospital, Ghatkopar (East), Mumbai, India

    S. S. Payannavar & A. P. Walvalkar

Authors
  1. Kavita K. Shalia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. K. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. R. Mashru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. L. Soneji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. B. Vasvani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. S. Payannavar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. P. Walvalkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. A. Mokal
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. M. Mithbawkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. K. V. Kudalkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. A. Abraham
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. P. K. Thakur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kavita K. Shalia.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shalia, K.K., Shah, V.K., Mashru, M.R. et al. Circulating thrombotic and haemostatic components in patients with coronary artery disease. Indian J Clin Biochem 25, 20–28 (2010). https://doi.org/10.1007/s12291-010-0005-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-010-0005-2

Key Words

  • Acute Myocardial Infarction
  • Non-ST elevated MI
  • Thrombotic and haemostatic components
  • Stable angina